NCT00347022View on ClinicalTrials.gov

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

PHASE4CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

June 30, 2009

Conditions
Diagnostic Imaging
Interventions
DRUG

Xenetix

300 mg of iodine/ml

DRUG

Visipaque

270 mg of iodine/ml

Trial Locations (1)

76031

CHU Charles Nicolle, Rouen

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT00347022 - A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications | Biotech Hunter | Biotech Hunter